BioNTech
Biyoteknoloji Şirketi
BioNTech SE, Almanya merkezli halka açık biyoteknoloji şirketi. Çeşitli hastalıkların tedavisi için hastaya özgü yaklaşım ile aktif immünoterapiler üretmektedir. Kanser immünoterapisi için mRNA tabanlı ilaçlar, bulaşıcı hastalıklar için aşılar ve... Vikipedi
Kurucuları: Uğur Şahin, Özlem Türeci ve Christoph Huber
CEO: Uğur Şahin (2008–)
Yan kuruluşları: InstaDeep Ltd, BioNTech US Inc., Aexerna Therapeutics ve diğer
İşletme Müdürü: Sierk Poetting
Kuruluş tarihi: 2008
Genel merkezi: Almanya
Kaynak: S&P Global Market Intelligence
Daha fazla göster
Daha az göster
We strive to exploit the full potential of the body's immune system by combining powerful new therapeutic mechanisms and a diverse array of biological targets ...
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the ...
Diğer sorular
Why BioNTech stocks are falling?
Did Pfizer buy BioNTech?
What does BioNTech do?
Is BioNTech a good company to work for?
Klinische Studien. Unser Ziel ist es, das volle Potenzial des körpereigenen Immunsystems auszuschöpfen. Hierfür kombinieren wir potente neue Wirkmechanismen mit ...
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to ...
BioNTech SE | 235302 followers on LinkedIn. Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious ...
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) Authorized For Individuals 6 Months through 11 Years of Age.
Our aim is to provide therapeutic benefits for cancer patients along the entire treatment journey. https://investors.biontech.de/news-releases/news-release- ...